{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:40:34Z","timestamp":1791999634507,"version":"4.4.0"},"reference-count":27,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T00:00:00Z","timestamp":1471305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T00:00:00Z","timestamp":1471305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1111\/dth.12384","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T08:52:39Z","timestamp":1471337559000},"page":"406-412","source":"Crossref","is-referenced-by-count":35,"title":["The role of systemic steroids and phototherapy in the treatment of stable vitiligo: a randomized controlled trial"],"prefix":"10.1155","volume":"29","author":[{"given":"Medhat","family":"El Mofty","sequence":"first","affiliation":[{"name":"Dermatology Department, Faculty of Medicine; Cairo University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Essmat","sequence":"additional","affiliation":[{"name":"Dermatology Department, Faculty of Medicine; Cairo University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa","family":"Youssef","sequence":"additional","affiliation":[{"name":"Dermatology Department, Faculty of Medicine; Cairo University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherine","family":"Sobeih","sequence":"additional","affiliation":[{"name":"Dermatology Department, Faculty of Medicine; Cairo University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"Mahgoub","sequence":"additional","affiliation":[{"name":"Dermatology Department, Faculty of Medicine; Cairo University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherine","family":"Ossama","sequence":"additional","affiliation":[{"name":"Dermatology Department, Faculty of Medicine; Cairo University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akmal","family":"Saad","sequence":"additional","affiliation":[{"name":"Dermatology Department, Faculty of Medicine; Cairo University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"El Tawdy","sequence":"additional","affiliation":[{"name":"Dermatology Department, Faculty of Medicine; Cairo University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba M.","family":"Mashaly","sequence":"additional","affiliation":[{"name":"Dermatology Department, Faculty of Medicine; Cairo University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Saney","sequence":"additional","affiliation":[{"name":"Dermatology Department, Faculty of Medicine; Cairo University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Helal","sequence":"additional","affiliation":[{"name":"Dermatology Department, Faculty of Medicine; Cairo University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfat","family":"Shaker","sequence":"additional","affiliation":[{"name":"Dermatology Department, Faculty of Medicine; Cairo University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2016,8,16]]},"reference":[{"key":"10.1111\/dth.12384-BIB0001|dth12384-cit-0001","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1755-148X.2011.00939.x","article-title":"Review: vitiligo as an inflammatory skin disorder: a therapeutic perspective","volume":"25","author":"Taieb","year":"2012","journal-title":"Pigm Cell Melanoma Res"},{"key":"10.1111\/dth.12384-BIB0002|dth12384-cit-0002","doi-asserted-by":"publisher","first-page":"e59782","DOI":"10.1371\/journal.pone.0059782","article-title":"Vitiligo: a possible model of degenerative diseases","volume":"8","author":"Bellei","year":"2013","journal-title":"PLoS One"},{"key":"10.1111\/dth.12384-BIB0003|dth12384-cit-0003","doi-asserted-by":"publisher","first-page":"1262r1","DOI":"10.6003\/jtad.1262r1","article-title":"Review: vitiligo as an autoimmune disease","volume":"6","author":"Kutlubay","year":"2012","journal-title":"J Turk Acad Dermatol"},{"key":"10.1111\/dth.12384-BIB0004|dth12384-cit-0004","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1600-0625.2007.00666.x","article-title":"Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance or what else?","volume":"17","author":"Schallreuter","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1111\/dth.12384-BIB0005|dth12384-cit-0005","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3109\/09546634.2013.777381","article-title":"Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasone and calcipotriol in vitiligo","volume":"25","author":"Akdeniz","year":"2014","journal-title":"J Dermatol Treat"},{"key":"10.1111\/dth.12384-BIB0006|dth12384-cit-0006","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/2013.jamadermatol.386","article-title":"The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo","volume":"149","author":"Grimes","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1111\/dth.12384-BIB0007|dth12384-cit-0007","first-page":"1","article-title":"An update on new and emerging options for the treatment of vitiligo","volume":"13","author":"Mahmoud","year":"2008","journal-title":"Skin Therapy Lett"},{"key":"10.1111\/dth.12384-BIB0008|dth12384-cit-0008","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","article-title":"Guidelines for the management of vitiligo, The European Dermatology Forum Consensus","volume":"168","author":"Taieb","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/dth.12384-BIB0009|dth12384-cit-0009","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.0906-6705.2004.00221.x","article-title":"Narrow-band ultraviolet-B stimulates proliferation and migration of cultured melanocytes","volume":"13","author":"Wu","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1111\/dth.12384-BIB0010|dth12384-cit-0010","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.EWX.0000407130.56575.30","article-title":"basic fibroblast growth factor & vitiligo","volume":"9","author":"Nada","year":"2012","journal-title":"J Egyptian Women's Dermatol Soc"},{"key":"10.1111\/dth.12384-BIB0011|dth12384-cit-0011","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/cdd.2011.132","article-title":"FGF2 regulates melanocytes viability through the STAT3-transactivated PAX3 transcription","volume":"19","author":"Dong","year":"2012","journal-title":"Cell Death"},{"key":"10.1111\/dth.12384-BIB0012|dth12384-cit-0012","doi-asserted-by":"publisher","first-page":"e102572","DOI":"10.1371\/journal.pone.0102572","article-title":"FRET based quantification and screening technology platform for the interactions of leukocyte function-associated antigen-1 (LFA-1) with intercellular adhesion molecule-1","volume":"9","author":"Chakraborty","year":"2014","journal-title":"PLoS One"},{"key":"10.1111\/dth.12384-BIB0013|dth12384-cit-0013","doi-asserted-by":"publisher","first-page":"e81736","DOI":"10.1371\/journal.pone.0081736","article-title":"Tumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibility","volume":"8","author":"Laddha","year":"2013","journal-title":"PLoS One"},{"key":"10.1111\/dth.12384-BIB0014|dth12384-cit-0014","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/1523-1747.ep12492607","article-title":"Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo","volume":"97","author":"Harning","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1111\/dth.12384-BIB0015|dth12384-cit-0015","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"den Boorn","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/dth.12384-BIB0016|dth12384-cit-0016","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","article-title":"Evidence for an autoimmune pathogenesis of vitiligo","volume":"16","author":"Ongenae","year":"2003","journal-title":"Pigm Cell Res"},{"key":"10.1111\/dth.12384-BIB0017|dth12384-cit-0017","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1067\/mjd.2001.113475","article-title":"Oral dexamethasone pulse treatment for vitiligo","volume":"44","author":"Radakovic-Fijan","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/dth.12384-BIB0018|dth12384-cit-0018","first-page":"127","volume-title":"Systemic corticosteroids. In: Wolverton SE, ed. Comprehensive dermatologic drug therapy","author":"Wolverton","year":"2001","edition":"2"},{"key":"10.1111\/dth.12384-BIB0019|dth12384-cit-0019","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1001\/archderm.1997.03890480045006","article-title":"Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A","volume":"133","author":"Westerhof","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1111\/dth.12384-BIB0020|dth12384-cit-0020","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2310\/7750.2013.12053","article-title":"Low-dose oral mini-pulse dexamethasone therapy in progressive unstable vitiligo","volume":"17","author":"Kanwar","year":"2013","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/dth.12384-BIB0021|dth12384-cit-0021","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4103\/0378-6323.42905","article-title":"An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad\/narrow band UVB phototherapy in progressive vitiligo","volume":"74","author":"Rath","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/dth.12384-BIB0022|dth12384-cit-0022","doi-asserted-by":"publisher","first-page":"498","DOI":"10.2340\/00015555-0161","article-title":"Basic fibroblast growth factor promotes melanocyte migration via increased expression of p125(FAK) on melanocytes","volume":"86","author":"Wu","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/dth.12384-BIB0023|dth12384-cit-0023","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1600-0749.2004.00198.x","article-title":"Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes","volume":"18","author":"Hirobe","year":"2005","journal-title":"Pigm Cell Res"},{"key":"10.1111\/dth.12384-BIB0024|dth12384-cit-0024","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1468-3083.2011.04368.x","article-title":"Basic fibroblast growth factor and tumour necrosis factor alpha in vitiligo and other hypopigmented disorders: suggestive possible therapeutic targets","volume":"27","author":"Seif El Nasr","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/dth.12384-BIB0025|dth12384-cit-0025","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1517\/14656566.2015.1087508","article-title":"Advances in the treatment options for vitiligo: activated low-dose cytokines-based therapy","volume":"16","author":"Lotti","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/dth.12384-BIB0026|dth12384-cit-0026","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1046\/j.1523-1747.2000.00130.x","article-title":"IgG anti-melanocyte antibodies purified from patients with active vitiligo induce hla-dr and intercellular adhesion molecule-1 expression and an increase in interleukin-8 release by melanocytes","volume":"115","author":"Li","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/dth.12384-BIB0027|dth12384-cit-0027","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/1523-1747.ep12476636","article-title":"Cytolytic antibodies to melanocytes in vitiligo","volume":"100","author":"Cui","year":"1993","journal-title":"J Invest Dermatol"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12384","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12384","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12384\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:56:06Z","timestamp":1671818166000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12384"}},"subtitle":["Oral mini-pulse steroids in Vitiligo"],"short-title":[],"issued":{"date-parts":[[2016,8,16]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"URL":"https:\/\/doi.org\/10.1111\/dth.12384","archive":["Portico"],"relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8,16]]}}}